Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolism of salt-retaining hormone by surviving liver slices.

Literature DB >> 13286344

Metabolism of salt-retaining hormone by surviving liver slices.

J J CHART, E S GORDON, P HELMER, M LESHER.

Abstract

Entities: Chemical

Keywords: ADRENAL CORTEX/hormones; LIVER/metabolism

Mesh：

Substances：
Adrenal Cortex Hormones

Year: 1956 PMID： 13286344 PMCID： PMC438802 DOI： 10.1172/JCI103270

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

25 in total

1. Primary aldosteronism.

Authors: J W CONN
Journal: J Lab Clin Med Date: 1955-04

2. The role of the liver and the adrenal in producing elevated plasma 17-hydroxycorticosteroid levels in surgery.

Authors: F H TYLER; C D SCHMIDT; K EIK-NES; H BROWN; L T SAMUELS
Journal: J Clin Invest Date: 1954-11 Impact factor: 14.808

3. [Constitution of aldosterone, a new mineralocorticoid].

Authors: S A SIMPSON; J F TAIT; A WETTSTEIN; R NEHER; J VON EUW; O SCHINDLER; T REICHSTEIN
Journal: Experientia Date: 1954-03-15

4. Excretion of sodium-retaining substances in patients with congestive heart failure.

Authors: B SINGER; J WENER
Journal: Am Heart J Date: 1953-06 Impact factor: 4.749

5. Studies in steroid metabolism. II. Metabolism of testosterone by human tissue slices.

Authors: H H WOTIZ; H M LEMON; A VOULGAROPOULOS
Journal: J Biol Chem Date: 1954-07 Impact factor: 5.157

6. The ability of the human liver to reduce the biologic activity of injected estrogens.

Authors: J M EVANS; J P YOUNG; R HERTZ; W W TULLNER; G WILMER; O WOOD
Journal: J Clin Endocrinol Metab Date: 1952-05 Impact factor: 5.958

7. Evidence for a sodium retaining factor in toxemia of pregnancy.

Authors: J J CHART; E G SHIPLEY; E S GORDON
Journal: Proc Soc Exp Biol Med Date: 1951-10

8. Treatment of nephrosis with pituitary adrenocorticotrophin.

Authors: J A LUETSCHER; Q B DEMING; B B JOHNSON; J HARVEY; W LEW; L J POO
Journal: J Clin Invest Date: 1951-12 Impact factor: 14.808

9. Abiological method for determining small quantities of sodium retaining substances.

Authors: C M KAGAWA; E G SHIPLEY; R K MEYER
Journal: Proc Soc Exp Biol Med Date: 1952-06

10. Sodium-retaining corticoid in the urine of normal children and adults and of patients with hypoadrenalism or hypopituitarism.

Authors: J A LUETSCHER; B J AXELRAD
Journal: J Clin Endocrinol Metab Date: 1954-09 Impact factor: 5.958

10 in total

Review 8. Ascites and oedema in liver disease.

Authors: M S Losowsky; B B Scott
Journal: Br Med J Date: 1973-08-11

9. [Shortened biological half-life period of 1,2-3H-aldosterone in 3 nephretomized patients].

Authors: J Möhring; W Siegenthaler; P Weidmann
Journal: Klin Wochenschr Date: 1968-01-01

10. [Studies with SU 4885 (metopirone) in patients with refractory ascites and edemas].

Authors: F H FRANKEN; K IRMSCHER; H von SCHWEINITZ
Journal: Klin Wochenschr Date: 1962-02-01

10 in total

Metabolism of salt-retaining hormone by surviving liver slices.

1. Primary aldosteronism.

2. The role of the liver and the adrenal in producing elevated plasma 17-hydroxycorticosteroid levels in surgery.

3. [Constitution of aldosterone, a new mineralocorticoid].

4. Excretion of sodium-retaining substances in patients with congestive heart failure.

5. Studies in steroid metabolism. II. Metabolism of testosterone by human tissue slices.

6. The ability of the human liver to reduce the biologic activity of injected estrogens.

7. Evidence for a sodium retaining factor in toxemia of pregnancy.

8. Treatment of nephrosis with pituitary adrenocorticotrophin.

9. Abiological method for determining small quantities of sodium retaining substances.

10. Sodium-retaining corticoid in the urine of normal children and adults and of patients with hypoadrenalism or hypopituitarism.

1. The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis.

2. Effect of oxygen therapy on oedema in patients with cor pulmonale.

3. [Aldosterone, glomerular filtration and sodium retention].

4. Discussion on endocrine changes in liver disease.

5. Unconsidered mechanisms responsible for maintaining the stability of the internal environment.

6. [Adrenal cortex and water and sodium metabolism with special reference to aldosterone].

7. Ascites in liver disease.

Review 8. Ascites and oedema in liver disease.

9. [Shortened biological half-life period of 1,2-3H-aldosterone in 3 nephretomized patients].

10. [Studies with SU 4885 (metopirone) in patients with refractory ascites and edemas].